Home > Insider Trading > Filing (0001209191-10-035418)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
949699	Pharmacyclics Inc	PCYC	Pharmaceutical Preparations (2834)	943148201

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1055919	W Robert Duggan	C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085	Chairman And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-06-21	1,075,268	$6.51	10,904,702	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,909,676	Indirect	Through RWD Acquisition I LLC
Common Stock	602,714	Indirect	Managed Accounts

Footnotes

Shares owned directly by RWD Acquisition LLC ("RWD Acquisition"). As the sole member of RWD Acquisition, Robert W. Duggan may be deemed to beneficially own the Shares owned by RWD Acquisition. Mr. Duggan disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.
Shares held in managed accounts pursuant to agreements with Robert W. Duggan & Associates ("RWD&A"), of which Robert W. Duggan is a principal. Mr. Duggan disclaims beneficial ownership of such Shares except to the extent of his pecuniary interest therein.